Tell your healthcare provider right away if you or your child become pregnant or think you may be pregnant during treatment with Lexapro. There is a pregnancy registry for females who are exposed to Lexapro during pregnancy. The purpose of the registry is to collect information about the health of females exposed to Lexapro and their baby.
Tell your healthcare provider right away if you or your child become pregnant or think you may be pregnant during treatment with Lexapro. There is a pregnancy registry for females who are exposed to Lexapro during pregnancy. The purpose of the registry is to collect information about the health of females exposed to Lexapro and their baby.
Tell your healthcare provider right away if you or your child become pregnant or think you may be pregnant during treatment with Lexapro. There is a pregnancy registry for females who are exposed to Lexapro during pregnancy. The purpose of the registry is to collect information about the health of females exposed to Lexapro and their baby.
Tell your healthcare provider right away if you or your child become pregnant or think you may be pregnant during treatment with Lexapro. There is a pregnancy registry for females who are exposed to Lexapro during pregnancy. The purpose of the registry is to collect information about the health of females exposed to Lexapro and their baby.
Tell your healthcare provider right away if you or your child become pregnant or think you may be pregnant during treatment with Lexapro. There is a pregnancy registry for females who are exposed to Lexapro during pregnancy. The purpose of the registry is to collect information about the health of females exposed to Lexapro and their baby.
classes) that included Advise women that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to LEXAPRO.
Lexapro oral solution contains escitalopram oxalate equivalent to 1 mg/mL escitalopram Infants exposed to LEXAPRO should be monitored for excess sedation
Tell your healthcare provider right away if you or your child become pregnant or think you may be pregnant during treatment with Lexapro. There is a pregnancy registry for females who are exposed to Lexapro during pregnancy. The purpose of the registry is to collect information about the health of females exposed to Lexapro and their baby.
The following information is for the Escitalopram Oxalate active ingredient Non-Teratogenic Effects: Neonates exposed to Lexapro and other
I think the “various ingredients” bar was met.